These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1387797)

  • 1. Cardiovascular effects of the novel potassium channel opener bimakalim in conscious pigs after myocardial infarction: a comparative study with nicorandil.
    van Woerkens LJ; Baas NR; van der Giessen WJ; Verdouw PD
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):409-17. PubMed ID: 1387797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs.
    Yao Z; Gross GJ
    Circulation; 1994 Apr; 89(4):1769-75. PubMed ID: 8149542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-ischaemic actions of potassium channel openers in experimental myocardial ischaemia/reperfusion injury in dogs.
    Auchampach JA; Gross GJ
    Eur Heart J; 1993 Jul; 14 Suppl B():10-5. PubMed ID: 8370365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of administration of nicorandil or bimakalim prior to and during ischemia or reperfusion on survival rate, ischemia/reperfusion-induced arrhythmias and infarct size in anesthetized rabbits.
    Das B; Sarkar C; Karanth KS
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):383-96. PubMed ID: 11692221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bimakalim (EMD 52692), an opener of ATP sensitive potassium channels, on infarct size, coronary blood flow, regional wall function, and oxygen consumption in swine.
    Rohmann S; Weygandt H; Schelling P; Soei LK; Becker KH; Verdouw PD; Lues I; Häusler G
    Cardiovasc Res; 1994 Jun; 28(6):858-63. PubMed ID: 7923292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relaxation of human coronary artery and arteria mammaria by K(+)-channel openers.
    Bossaller C; Auch-Schwelk W; Graf K; Gräfe M; Catadelgirmen G; Ennker J; Fleck E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S13-6. PubMed ID: 1282170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine A1 receptor blockade does not abolish the cardioprotective effects of the adenosine triphosphate-sensitive potassium channel opener bimakalim.
    Gross GJ; Mei DA; Sleph PG; Grover GJ
    J Pharmacol Exp Ther; 1997 Feb; 280(2):533-40. PubMed ID: 9023261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular profile of 5 novel nitrate-esters: a comparative study with nitroglycerin in pigs with and without left ventricular dysfunction.
    van Woerkens LJ; van der Giessen WJ; Verdouw PD
    Br J Pharmacol; 1991 Sep; 104(1):7-14. PubMed ID: 1786521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicorandil-induced changes in the distribution of cardiac output and coronary blood flow in pigs.
    Verdouw PD; Sassen LM; Duncker DJ; Schmeets IO; Rensen RJ; Saxena PR
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Sep; 336(3):352-8. PubMed ID: 2960904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in myocardial infarct size by the new potassium channel opener bimakalim.
    Auchampach JA; Gross GJ
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):554-61. PubMed ID: 7516004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs.
    Mizumura T; Nithipatikom K; Gross GJ
    Circulation; 1995 Sep; 92(5):1236-45. PubMed ID: 7648671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of elgodipine in conscious pigs with a normal coronary circulation and in conscious pigs with a healed myocardial infarction.
    van Woerkens LJ; Schotman SN; van der Giessen WJ; Verdouw PD
    J Cardiovasc Pharmacol; 1991 Jun; 17(6):976-82. PubMed ID: 1714024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bimakalim on human cardiac action potentials: comparison with guinea pig and nicorandil and use-dependent study.
    Rouet R; Picard S; Criniti A; Monti F; Dawodu AA; Ruvolo G; La Francesca S; Macrina F; Tonelli E; Ducouret P; Puddu PE
    J Cardiovasc Pharmacol; 1999 Feb; 33(2):255-63. PubMed ID: 10028934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic profile of the potassium channel activator EMD 52692 in anaesthetized pigs.
    Sassen LM; Duncker DJ; Gho BC; Diekmann HW; Verdouw PD
    Br J Pharmacol; 1990 Nov; 101(3):605-14. PubMed ID: 2076480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitation of myocardial infarct size by nicorandil after sustained ischemia in pigs.
    Galiè N; Guarnieri C; Ussia GP; Zimarino M; Traini AM; Parlangeli R; Vaona I; Branzi A; Magnani B
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):477-84. PubMed ID: 8583791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lack of bronchodilator effect and the short-term safety of cumulative single doses of an inhaled potassium channel opener (bimakalim) in adult patients with mild to moderate bronchial asthma.
    Faurschou P; Mikkelsen KL; Steffensen I; Franke B
    Pulm Pharmacol; 1994 Oct; 7(5):293-7. PubMed ID: 7626915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotective effects of nicorandil.
    Gross GJ; Auchampach JA; Maruyama M; Warltier DC; Pieper GM
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S22-8. PubMed ID: 1282172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of anti-ischemic efficacy of the potassium channel opener bimakalim in patients with stable angina pectoris.
    Burian M; Piske M; Petkovic D; Mitrovic V
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):37-46. PubMed ID: 15115902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent hemodynamic effects of bimakalim, a new potassium channel opener, in humans.
    Senior R; Buchner-Moell D; Raftery E; Lahiri A
    J Cardiovasc Pharmacol; 1993 Nov; 22(5):717-21. PubMed ID: 7506324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of pulmonary and systemic vascular responses to cromakalim, an activator of K+ATP channels.
    Minkes RK; Kvamme P; Higuera TR; Nossaman BD; Kadowitz PJ
    Am J Physiol; 1991 Mar; 260(3 Pt 2):H957-66. PubMed ID: 1825747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.